Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Impact of Intermittent Preventive Malaria Treatment With Artemisinin Combination Therapy (ACT) on Hemoglobin, Malaria, Schistosomiasis, and School Attention Among Primary Schoolchildren in the Kassena-Nankana Districts, Ghana

NCT01459146 is registered in ClinicalTrials.gov with Navrongo Health Research Centre, Ghana as lead sponsor.

NCT NCT01459146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01459146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Impact of Intermittent Preventive Malaria Treatment With Artemisinin Combination Therapy (ACT) on Hemoglobin, Malaria, Schistosomiasis, and School Attention Among Primary Schoolchildren in the Kassena-Nankana Districts, Ghana
Lead sponsor
Navrongo Health Research Centre, Ghana
Phase
Phase 4
Overall status
Unknown status
Start date
December 31, 2010
Completion date
November 30, 2012
Enrollment
345 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, change in sustained attention, helminthiasis, malaria, schistosomiasis